Insider · CIK 0001279309

KING THOMAS BRAXTON

Reports to the SEC for 5 companies · MOUNTAIN VIEW, CA

sec.gov

Transactions

Companies

Filings

CIK

0001279309

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-09-04	ACHVACHIEVE LIFE SCIENCES, INC.M Exercise/Conversion	Director	MExercise/Conversion	+455K sh	—	—	455,000
2025-09-04	ACHVACHIEVE LIFE SCIENCES, INC. · Performance Restricted Stock Unit (PRSU)M Exercise/Conversion	Director	MExercise/Conversion	−455K sh	—	—	0
2025-09-04	ACHVACHIEVE LIFE SCIENCES, INC.S Sale	Director	SSale	−140K sh	$2.77	−$387K	315,142
2025-06-06	ACHVACHIEVE LIFE SCIENCES, INC. · Stock Option (right to buy)A Award	Director	AAward	+31.5K sh	—	—	31,500
2025-01-13	ACHVACHIEVE LIFE SCIENCES, INC. · Stock Option (right to buy)A Award	Director	AAward	+195K sh	—	—	195,000
2025-01-13	ACHVACHIEVE LIFE SCIENCES, INC. · Performance Restricted Stock Unit (PRSU)A Award	Director	AAward	+455K sh	—	—	455,000
2024-07-03	TFF Pharmaceuticals, Inc.Stock Options (Right to Buy)A Award	Director	AAward	+1,583 sh	—	—	1,583
2024-07-03	TFF Pharmaceuticals, Inc.A Award	Director	AAward	+1,583 sh	—	—	1,583
2024-04-18	TFF Pharmaceuticals, Inc.Restricted stock unitsA Award	Director	AAward	+3,110 sh	—	—	3,110
2024-01-22	ACHVACHIEVE LIFE SCIENCES, INC. · Stock Option (right to buy)A Award	Director	AAward	+31.5K sh	—	—	31,500
2023-12-13	TFF Pharmaceuticals, Inc.Stock Options (Right to Buy)A Award	Director	AAward	+132K sh	—	—	132,442
2023-06-08	Satsuma Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12.8K sh	—	—	0
2023-06-08	Satsuma Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−14.9K sh	—	—	0
2023-06-08	Satsuma Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−10K sh	—	—	0
2023-06-08	Satsuma Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−20K sh	—	—	0
2023-06-08	Satsuma Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−30K sh	—	—	0
2023-06-08	Satsuma Pharmaceuticals, Inc.Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12.8K sh	—	—	0
2023-03-29	ACHVACHIEVE LIFE SCIENCES, INC. · Stock Option (right to buy)A Award	Director	AAward	+24K sh	—	—	24,000
2023-03-29	ACHVACHIEVE LIFE SCIENCES, INC. · Stock Option (right to buy)A Award	Director	AAward	+23.3K sh	—	—	23,250
2022-06-03	Satsuma Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+30K sh	—	—	30,000
2020-12-03	Satsuma Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+20K sh	—	—	20,000
2020-06-12	Satsuma Pharmaceuticals, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2020-02-20	VIVUS INCNon-Qualified Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2018-10-26	VIVUS INCNon-Qualified Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2018-06-15	VIVUS INCEmployee Stock Option (right to buy)A Award	Director	AAward	+200K sh	—	—	200,000
2018-01-26	VIVUS INCEmployee Stock Option (right to buy)A Award	Director	AAward	+600K sh	—	—	600,000
2017-07-27	VIVUS INCEmployee Stock Option (right to buy)A Award	Director	AAward	+125K sh	—	—	125,000
2016-06-21	Alexza Pharmaceuticals Inc.Stock Option (right to buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−9,921 sh	—	—	0
2016-06-21	Alexza Pharmaceuticals Inc.Stock Option (right to buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−5,453 sh	—	—	0
2016-06-21	Alexza Pharmaceuticals Inc.Stock Option (right to buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−19.6K sh	—	—	0
2016-06-21	Alexza Pharmaceuticals Inc.Stock Option (right to buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−33.4K sh	—	—	0
2016-06-21	Alexza Pharmaceuticals Inc.Stock Option (right to buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−50K sh	—	—	0
2016-06-21	Alexza Pharmaceuticals Inc.Stock Option (right to buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−50K sh	—	—	0
2016-06-21	Alexza Pharmaceuticals Inc.Stock Option (right to buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−400K sh	—	—	0
2016-06-21	Alexza Pharmaceuticals Inc.Common Stock Warrant (right to buy)D Disposition to Issuer	Director, President & CEO	DDisposition to Issuer	−5,818.969 sh	—	—	0
2016-06-21	Alexza Pharmaceuticals Inc.U Disposition from Tender	Director, President & CEO	UDisposition from Tender	−40K sh	—	—	0
2016-06-21	Alexza Pharmaceuticals Inc.U Disposition from Tender	Director, President & CEO	UDisposition from Tender	−37.2K sh	—	—	0
2015-07-22	Alexza Pharmaceuticals Inc.Stock Option (right to buy)A Award	Director, President & CEO	AAward	+400K sh	—	—	400,000
2013-07-26	Alexza Pharmaceuticals Inc.P Purchase	Director, President & CEO	PPurchase	+2,420 sh	$4.49	+$10.9K	215,000
2013-07-26	Alexza Pharmaceuticals Inc.P Purchase	Director, President & CEO	PPurchase	+2,420 sh	$4.49	+$10.9K	215,000
2013-07-25	Alexza Pharmaceuticals Inc.P Purchase	Director, President & CEO	PPurchase	+12.6K sh	$4.50	+$56.6K	212,580
2013-07-25	Alexza Pharmaceuticals Inc.P Purchase	Director, President & CEO	PPurchase	+12.6K sh	$4.50	+$56.6K	212,580
2013-07-24	Alexza Pharmaceuticals Inc.P Purchase	Director, President & CEO	PPurchase	+25K sh	$4.48	+$112K	200,000
2013-07-24	Alexza Pharmaceuticals Inc.P Purchase	Director, President & CEO	PPurchase	+25K sh	$4.48	+$112K	200,000
2013-03-29	Alexza Pharmaceuticals Inc.Stock Option (right to buy)A Award	Director, President & CEO	AAward	+350K sh	—	—	350,000
2013-03-29	Alexza Pharmaceuticals Inc.A Award	Director, President & CEO	AAward	+175K sh	$4.42	+$774K	175,000
2013-02-25	Alexza Pharmaceuticals Inc.G Gift	Director, President & CEO	GGift	−9,113 sh	—	—	0
2013-02-25	Alexza Pharmaceuticals Inc.G Gift	Director, President & CEO	GGift	+9,113 sh	—	—	30,149
2012-08-27	Alexza Pharmaceuticals Inc.S Sale	Director, President & CEO	SSale	−10K sh	$4.14	−$41.4K	10,229
2012-08-14	Alexza Pharmaceuticals Inc.G Gift	Director, President & CEO	GGift	−1,116 sh	—	—	9,113

Recent filings

Accepted (ET)
Sep 84
KING THOMAS BRAXTON0000950170-25-113591
SEC(opens sec.gov)
Jun 104
KING THOMAS BRAXTON0000950170-25-084415
SEC(opens sec.gov)
Jan 144
KING THOMAS BRAXTON0000950170-25-005392
SEC(opens sec.gov)
Jul 84
KING THOMAS BRAXTON0001213900-24-059871
SEC(opens sec.gov)
Apr 224
KING THOMAS BRAXTON0001213900-24-035085
SEC(opens sec.gov)
Jan 244
KING THOMAS BRAXTON0001209191-24-002207
SEC(opens sec.gov)
Dec 154
KING THOMAS BRAXTON0001213900-23-096082
SEC(opens sec.gov)
Jun 94
KING THOMAS BRAXTON0001209191-23-035787
SEC(opens sec.gov)
Jun 84
KING THOMAS BRAXTON0000899243-23-014876
SEC(opens sec.gov)
Mar 304
KING THOMAS BRAXTON0001209191-23-021585
SEC(opens sec.gov)
Jun 74
KING THOMAS BRAXTON0001567619-22-012468
SEC(opens sec.gov)

Companies

Address

ALEXZA PHARMACEUTICALS INC. 2091 STIERLIN COURT

MOUNTAIN VIEW, CA, 94043